Why APRETUDE?

Bring on a different way to help you stay continually protected from HIV.

Why APRETUDE?

Bring on a different way to help you stay continually protected from HIV.

All about long-acting APRETUDE:

The first and only long-acting, injectable PrEP for reducing the risk of getting HIV

Designed to continuously help prevent the risk of getting HIV when taken every other month

No daily PrEP pills to remember
or keep track of while you are receiving your APRETUDE injection every other month

Designed to continuously help prevent the risk of getting HIV when taken every other month

No daily PrEP pills to remember
or keep track of while you are receiving your APRETUDE injection every other month

Designed to continuously help prevent the risk of getting HIV when taken every other month

APRETUDE is given every other month by a healthcare provider after initiation injections have been given 1 month apart for 2 consecutive months. Stay under a provider’s care while receiving APRETUDE. You must receive it as scheduled. If you will miss a scheduled injection by more than 7 days, call your provider right away.

How is APRETUDE different?

It’s an injection given by your healthcare provider every other month, instead of a pill you take every day

Per the CDC, it is very important to take your PrEP as prescribed to effectively help protect against HIV.

APRETUDE

Continuous protection with as few as 6 injections a year*

*After 2 once-monthly starter doses.

A Daily PrEP Pill

Daily oral doses required

Per the CDC, it is very important to take your PrEP as prescribed to effectively help protect against HIV.

APRETUDE

Continuous protection with as few as 6 injections a year*

A Daily PrEP Pill

Daily oral doses required

*After 2 once-monthly starter doses.

Learn about our clinical studies

Is long-acting PrEP right for me?

CBTWCNT220078

ARROW

IMPORTANT SAFETY INFORMATION

What is the most important thing I should know about APRETUDE?

Before receiving APRETUDE to reduce your risk of getting HIV-1, you must be HIV-1 negative to start APRETUDE. Do not receive APRETUDE unless you are tested and confirmed to be HIV-1 negative.

Some HIV-1 tests can miss HIV-1 infection in a person who has recently become infected. Tell your healthcare provider if you had a flu-like illness within the last month before starting or at any time while receiving APRETUDE. Symptoms of new HIV-1 infection include: tiredness; joint or muscle aches; sore throat; rash; enlarged lymph nodes in the neck or groin; fever; headache; vomiting or diarrhea; or night sweats

While you are receiving APRETUDE for HIV-1 PrEP:

APRETUDE does not prevent other sexually transmitted infections (STIs). Practice safer sex by using a latex or polyurethane condom to reduce the risk of getting STIs

You must stay HIV-1 negative to keep receiving APRETUDE for HIV-1 PrEP

Know your HIV-1 status and the HIV-1 status of your partners. If you think you were exposed to HIV-1, tell your healthcare provider right away
Your risk of getting HIV-1 is lower if your partners with HIV-1 are taking effective treatment
Get tested for HIV-1 with each APRETUDE injection or when your healthcare provider tells you. You should not miss any HIV-1 tests. If you become HIV-1 infected and continue receiving APRETUDE because you do not know you are HIV-1 infected, the HIV-1 infection may become harder to treat
Get tested for other STIs. These infections make it easier for HIV-1 to infect you
Talk to your healthcare provider about ways to reduce your HIV-1 risk
Do not miss any injections of APRETUDE. Missing injections increases your risk of getting HIV-1 infection

Who should not receive APRETUDE?

Do not receive APRETUDE if you:

already have HIV-1 or do not know your HIV-1 status. If you are HIV-1 positive, you need to take other medicines to treat HIV-1. APRETUDE can only help reduce your risk of getting HIV-1 infection before you are infected. If you have HIV-1 and receive only APRETUDE, over time, your HIV-1 may become harder to treat

are allergic to cabotegravir

are taking certain medicines: carbamazepine; oxcarbazepine; phenobarbital; phenytoin; rifampin; or rifapentine

What are the possible side effects of APRETUDE?

APRETUDE may cause serious side effects:

Allergic reactions. Call your healthcare provider right away if you develop a rash with APRETUDE. Stop receiving APRETUDE and get medical help right away if you develop a rash with any of the following signs or symptoms: fever; generally ill feeling; tiredness; muscle or joint aches; trouble breathing; blisters or sores in mouth; blisters; redness or swelling of the eyes; swelling of the mouth, face, lips, or tongue

Liver problems. Liver problems have happened in people with or without a history of liver problems or other risk factors. Call your healthcare provider right away if you have any of the following symptoms: your skin or the white part of your eyes turns yellow; dark or “tea-colored” urine; light-colored stools; nausea or vomiting; loss of appetite; pain, aching, or tenderness on the right side of your stomach area; or itching

Depression or mood changes. Call your healthcare provider or get emergency medical help right away if you have any of the following symptoms: feeling sad or hopeless; feeling anxious or restless; have thoughts of hurting yourself (suicide) or have tried to hurt yourself

The most common side effects of APRETUDE include:

Pain, tenderness, hardened mass or lump, swelling, bruising, redness, itching, warmth, loss of sensation at the injection site, abscess, and discoloration; diarrhea; headache; fever; tiredness; sleep problems; nausea; dizziness; passing gas; stomach pain; vomiting; muscle pain; rash; loss of appetite; drowsiness; back pain; or upper respiratory infection

These are not all the possible side effects of APRETUDE. Call your healthcare provider for medical advice about side effects

Before receiving APRETUDE, tell your healthcare provider about all your medical conditions, including if you:

have ever had a skin rash or an allergic reaction to medicines that contain cabotegravir

have or have had liver problems

have ever had mental health problems

are pregnant or plan to become pregnant. It is not known if APRETUDE will harm your unborn baby. APRETUDE can remain in your body for up to 12 months or longer after the last injection. Tell your healthcare provider if you become pregnant while receiving APRETUDE

are breastfeeding or plan to breastfeed. It is not known if APRETUDE can pass to your baby in your breast milk. Talk with your healthcare provider about the best way to feed your baby while receiving APRETUDE

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Some medicines may interact with APRETUDE. Keep a list of your medicines and show it to your healthcare provider and pharmacist. Do not start a new medicine without telling your healthcare provider

How will I receive APRETUDE?

APRETUDE is initially given as an injection into the muscle of your buttock 1 time every month for the first 2 months, then as an injection 1 time every 2 months

Before receiving your first APRETUDE injection, your healthcare provider may have you take 1 oral cabotegravir tablet 1 time a day for 1 month (at least 28 days) to assess how well you tolerate cabotegravir

APRETUDE is a long-acting medicine and may stay in your body for 12 months or longer after your last injection

Stay under the care of a healthcare provider while receiving APRETUDE. It is important that you receive APRETUDE as scheduled

If you miss or plan to miss a scheduled injection of APRETUDE by more than 7 days, call your healthcare provider right away to discuss your PrEP options

If you stop receiving APRETUDE, talk to your healthcare provider about other options to reduce the risk of getting HIV-1 infection

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please read the Patient Information for APRETUDE and discuss it with your healthcare provider.

CBTWCNT220041

Trademarks are owned by or licensed to the ViiV Healthcare group of companies.

This website is funded and developed by ViiV Healthcare. This site is intended for US residents only.